Epoch Investment Partners’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-706,570
| Closed | -$4.8M | – | 463 |
|
|
2023
Q1 | $4.8M | Sell |
706,570
-690,707
| -49% | -$4.69M | 0.03% | 297 |
|
|
2022
Q4 | $10.3M | Sell |
1,397,277
-1,326,875
| -49% | -$9.81M | 0.06% | 269 |
|
|
2022
Q3 | $26.9M | Sell |
2,724,152
-33,494
| -1% | -$331K | 0.18% | 173 |
|
|
2022
Q2 | $30.1M | Buy |
2,757,646
+178,434
| +7% | +$1.94M | 0.18% | 170 |
|
|
2022
Q1 | $29.2M | Buy |
2,579,212
+617,829
| +31% | +$6.99M | 0.14% | 183 |
|
|
2021
Q4 | $30.8M | Sell |
1,961,383
-19,514
| -1% | -$306K | 0.16% | 173 |
|
|
2021
Q3 | $34M | Buy |
1,980,897
+136,207
| +7% | +$2.33M | 0.19% | 159 |
|
|
2021
Q2 | $39.7M | Buy |
1,844,690
+685,481
| +59% | +$14.7M | 0.21% | 140 |
|
|
2021
Q1 | $17.4M | Buy |
+1,159,209
| New | +$17.4M | 0.08% | 201 |
|